Luoyang Fudau Biotech Co., Ltd.

  Choosing the right cell culture flask is essential for achieving reliable and reproducible cell culture results. One of the most important factors to consider is whether to use a TC-treated cell culture flask or a non-treated cell culture flask. Although both types are widely used in laboratories, biotechnology companies, and pharmaceutical research facilities, they are designed for different applications. Understanding the differences between TC-treated and non-treated surfaces can help researchers improve cell attachment, growth performance, and experimental outcomes. In this guide, we compare TC-treated vs non-treated cell culture flasks, discuss their applications, and provide practical recommendations for selecting the right flask for your cell culture workflow. Tissue Culture Flasks What Is a TC-Treated Cell Culture Flask? A TC-treated cell culture flask is a flask that has undergone a specialized surface treatment process to enhance cell attachment and spreading...

  Vero cells have become one of the most widely used cell lines in vaccine research and production. Derived from African green monkey kidney cells, Vero cells are highly susceptible to a variety of viruses, making them an ideal platform for developing vaccines against diseases such as polio, rabies, influenza, Japanese encephalitis, and COVID-19. However, successful Vero cell culture requires careful control of culture conditions, vessel selection, and scale-up strategies. Researchers often encounter several challenges during vaccine development that can impact cell growth, virus yield, and overall production efficiency. Tissue Culture Flasks Why Vero Cells Are Important for Vaccine Research Vero cells are anchorage-dependent cells that require a suitable surface for attachment and proliferation. Their ability to support viral replication makes them a preferred host system for vaccine production. In early-stage vaccine research, scientists typically use TC-treated cell culture flas...

  Influenza remains one of the most significant infectious diseases worldwide, driving continuous demand for safe and effective vaccines. As vaccine manufacturers seek scalable and cost-efficient production platforms, the use of a Cell Factory  has become increasingly important in modern influenza vaccine manufacturing. Compared with traditional egg-based production systems, cell culture technologies provide greater flexibility, improved consistency, and faster response to emerging influenza strains. This article explores how a Cell Factory for Influenza Vaccine Production supports large-scale cell expansion and contributes to efficient vaccine manufacturing processes. Cell Factory 10 Layers TC-treated The Shift Toward Cell-Based Influenza Vaccine Production For decades, influenza vaccines were primarily produced using embryonated chicken eggs. While this approach remains widely used, it presents several limitations, including long production cycles, dependence on egg sup...